BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 34,012	$ 36,810
Grant receivables	2,951	9,923
Prepaid expenses and other current assets	586	1,068
Restricted cash equivalents	750	190
Total current assets	38,299	47,991
Property and equipment, net	87	93
Right-of-use assets, operating leases	510	306
Total assets	38,896	48,390
Current liabilities:
Accounts payable	673	1,119
Accrued expenses	3,833	11,995
Deferred grant income, current	777	367
Operating lease liabilities, current	89	136
Other current liabilities	78	307
Total current liabilities	5,450	13,924
Operating lease liabilities, non-current	422	195
Total liabilities	5,872	14,119
Commitments and contingencies (Note 6)
Stockholders' equity:
Preferred stock, $0.001 par value, 10,000,000 shares authorized; no shares issued and outstanding at June 30, 2026 and December 31, 2025
Common stock, $0.001 par value, 250,000,000 shares authorized; 95,055,773 and 88,904,161 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively	95	90
Additional paid-in capital	240,078	232,828
Accumulated deficit	(207,149)	(198,647)
Total stockholders' equity	33,024	34,271
Total liabilities and stockholders' equity	$ 38,896	$ 48,390

The amount of current portion of deferred grant income as at the end of the reporting period.

No definition available.

Name:	cgtx_DeferredGrantIncomeCurrent
Namespace Prefix:	cgtx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).